Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidocaine + oxycodone is a combination drug consisting of lidocaine, a local anesthetic, and oxycodone, an opioid analgesic. Lidocaine works by blocking sodium channels in neuronal cell membranes, thereby inhibiting nerve impulse conduction and producing local or regional anesthesia. Oxycodone acts primarily as an agonist at the mu-opioid receptor in the central nervous system to alter pain perception and response. This combination would theoretically provide both rapid-onset local anesthesia (from lidocaine) and systemic pain relief (from oxycodone), potentially for procedures or conditions requiring both modalities of analgesia[1][6]. However, there is no evidence from the provided sources that this specific combination is marketed under a unique brand name or widely approved as a fixed-dose product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine + oxycodone.